Revu Corporation (KOSDAQ:443250)
South Korea · Delayed Price · Currency is KRW 6,420.00
-50.00 (-0.77%)
At close: Aug 14, 2026
Revu Corporation Revenue
Revu Corporation had revenue of 13.27B KRW in the quarter ending March 31, 2026, with 11.06% growth. This brings the company's revenue in the last twelve months to 57.78B, up 15.16% year-over-year. In the year 2025, Revu Corporation had annual revenue of 56.46B with 18.05% growth.
Revenue (ttm)
57.78B
Revenue Growth
+15.16%
P/S Ratio
1.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
71.14B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.46B | 8.63B | 18.05% |
| Dec 31, 2024 | 47.82B | 8.08B | 20.32% |
| Dec 31, 2023 | 39.75B | -521.35M | -1.29% |
| Dec 31, 2022 | 40.27B | 17.28B | 75.19% |
| Dec 31, 2021 | 22.99B | 5.68B | 32.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Taewoong Logistics | 1.12T |
| Korea Parts & Fasteners Co.,Ltd | 731.45B |
| BioSmart | 515.82B |
| Creverse | 219.11B |
| Cenit | 129.39B |
| Hwail Pharmaceutical | 107.87B |
| Korea New Network | 68.03B |
| Black Yak I&C Co.,Ltd | 67.01B |